Phase II study of weekly albumin-bound paclitaxel combined with cisplatin in patients with advanced breast cancer

被引：0
|
作者：
Hu, X. [1 ]
Wang, B. [1 ]
机构：
[1] Fudan Univ, Canc Hosp, Shanghai 200433, Peoples R China
来源：
BREAST | 2011年 / 20卷
关键词：
D O I：
10.1016/S0960-9776(11)70254-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S77 / S77
页数：1
相关论文
共 50 条
  • [41] Bevacizumab and albumin-bound paclitaxel treatment in metastatic breast cancer
    Link, John S.
    Waisman, James R.
    Nguyen, Bichlien
    Jacobs, Cheryl I.
    CLINICAL BREAST CANCER, 2007, 7 (10) : 779 - 783
  • [42] Bevacizumab and albumin-bound paclitaxel treatment in metastatic breast cancer
    Link, J. S.
    Waisman, J. R.
    Nguyen, B.
    Jacobs, C. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [43] Evaluation of neoadjuvant weekly nanoparticle albumin-bound paclitaxel for HER2-negative breast cancer
    Nagayama, A.
    Matsui, A.
    Tachibana, A.
    Suzuki, N.
    Hirata, M.
    Oishi, Y.
    Hamaguchi, Y.
    Murata, Y.
    Okamoto, Y.
    ANNALS OF ONCOLOGY, 2016, 27
  • [44] Phase II Multicenter Trial of Albumin-Bound Paclitaxel and Capecitabine in First-Line Treatment of Patients With Metastatic Breast Cancer
    Schwartzberg, Lee S.
    Arena, Francis P.
    Mintzer, David M.
    Epperson, Amanda L.
    Walker, Mark S.
    CLINICAL BREAST CANCER, 2012, 12 (02) : 87 - 93
  • [45] Weekly paclitaxel in metastatic breast cancer patients: A phase II study
    Gori, S
    Mosconi, AM
    Basurto, C
    Cherubini, R
    De Angelis, V
    Tonato, M
    Colozza, M
    TUMORI, 2002, 88 (06) : 470 - 473
  • [46] A phase I study of combination therapy with nanoparticle albumin-bound paclitaxel and cyclophosphamide in patients with metastatic or recurrent breast cancer
    Goro Kutomi
    Tousei Ohmura
    Fukino Satomi
    Hideki Maeda
    Hiroaki Shima
    Hidekazu Kameshima
    Minoru Okazaki
    Hideji Masuoka
    Kenichi Sasaki
    Koichi Hirata
    International Journal of Clinical Oncology, 2015, 20 : 474 - 479
  • [47] A phase I study of combination therapy with nanoparticle albumin-bound paclitaxel and cyclophosphamide in patients with metastatic or recurrent breast cancer
    Kutomi, Goro
    Ohmura, Tousei
    Satomi, Fukino
    Maeda, Hideki
    Shima, Hiroaki
    Kameshima, Hidekazu
    Okazaki, Minoru
    Masuoka, Hideji
    Sasaki, Kenichi
    Hirata, Koichi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (03) : 474 - 479
  • [48] Weekly nanoparticle albumin-bound paclitaxel and paclitaxel for relapsed small cell lung cancer A retrospective observational study
    Oi, Hajime
    Matsuda, Toshiaki
    Kimura, Tomoki
    Morise, Masahiro
    Yamano, Yasuhiko
    Yokoyama, Toshiki
    Kataoka, Kensuke
    Kondoh, Yasuhiro
    MEDICINE, 2022, 101 (06) : E28863
  • [49] A phase II, multicenter, single-arm study of tri-weekly low-dose nanoparticle albumin-bound paclitaxel chemotherapy for patients with metastatic or recurrent breast cancer
    Shigeru Yamamoto
    Noriko Maeda
    Yukiko Nagashima
    Hidefumi Kubo
    Yoko Sato
    Hiroto Matsui
    Yuka Inoue
    Yoshitaro Shindo
    Shinsuke Kanekiyo
    Kazuhiko Sakamoto
    Nobuaki Suzuki
    Shigeru Takeda
    Tomio Ueno
    Shigefumi Yoshino
    Shoichi Hazama
    Masaaki Oka
    Hiroaki Nagano
    Breast Cancer, 2017, 24 : 783 - 789
  • [50] A phase II, multicenter, single-arm study of tri-weekly low-dose nanoparticle albumin-bound paclitaxel chemotherapy for patients with metastatic or recurrent breast cancer
    Yamamoto, Shigeru
    Maeda, Noriko
    Nagashima, Yukiko
    Kubo, Hidefumi
    Sato, Yoko
    Matsui, Hiroto
    Inoue, Yuka
    Shindo, Yoshitaro
    Kanekiyo, Shinsuke
    Sakamoto, Kazuhiko
    Suzuki, Nobuaki
    Takeda, Shigeru
    Ueno, Tomio
    Yoshino, Shigefumi
    Hazama, Shoichi
    Oka, Masaaki
    Nagano, Hiroaki
    BREAST CANCER, 2017, 24 (06) : 783 - 789
12345